LEXX - Latest News
Lexaria Bioscience Corp. (LEXX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $12.5M. Beta to the broader market is 0.36.
The article list below shows the most recent LEXX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent LEXX Headlines
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
accessnewswire.com - May 19, 2026
KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug d
Lexaria Bioscience Releases Second Episode of Investor Video Series
accessnewswire.com - May 7, 2026
CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities KELOWNA, BC / ACCESS Newswire / M
Lexaria Bioscience Releases Second Episode of Investor Video Series
thenewswire.com - May 7, 2026
CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Research Priorities Kelowna, British Columbia – May
Lexaria Updates Progress on Human Study #7
accessnewswire.com - May 5, 2026
KELOWNA, BC / ACCESS Newswire / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug de
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
accessnewswire.com - May 1, 2026
Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity and Commercial Strategy KELOWNA, BC / ACCESS Newswir
How News Affects LEXX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LEXX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked LEXX news questions
- What is the latest LEXX news headline?
- The most recent LEXX headline (May 19, 2026) is "Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the LEXX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What LEXX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual LEXX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.